Raymond James Financial Services Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $788K | Sell |
|
|||||
|
2024
Q2 | $860K | Buy |
|
|||||
|
2024
Q1 | $1.03M | Buy |
|
|||||
|
2023
Q4 | $1.1M | Buy |
|
|||||
|
2023
Q3 | $1.01M | Buy |
|
|||||
|
2023
Q2 | $1.08M | Buy |
|
|||||
|
2023
Q1 | $898K | Buy |
|
|||||
|
2022
Q4 | $810K | Sell |
|
|||||
|
2022
Q3 | $1.44M | Sell |
|
|||||
|
2022
Q2 | $1.33M | Sell |
|
|||||
|
2022
Q1 | $1.9M | Sell |
|
|||||
|
2021
Q4 | $4.47M | Buy |
|
|||||
|
2021
Q3 | $4.7M | Buy |
|
|||||
|
2021
Q2 | $5.61M | Sell |
|
|||||
|
2021
Q1 | $2.95M | Buy |
|
|||||
|
2020
Q4 | $1.3M | Buy |
|
|||||
|
2020
Q3 | $309K | Sell |
|
|||||
|
2020
Q2 | $1.54M | Buy |
|
|||||
|
2020
Q1 | $132K | Sell |
|
|||||
|
2019
Q4 | $187K | Buy |
|